|« Previous month||Next month »|
30-Aug-2012 - Hospira has bought Orchid Chemicals and Pharmaceutical’s active pharmaceutical ingredient (API) facility in Aurangabad, India, to support its expanding antibiotic business.
30-Aug-2012 - Regulatory professionals working for contract research organisations (CROs) in emerging markets could benefit from taking a test to bring them up to par with those in developed countries, according to...
30-Aug-2012 - QPS has boosted its late phase offering after acquiring Austrian-based JSW Life Sciences.
30-Aug-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest chops and changes in the world of pharmaceuticals, including news from INC Research, Y-Prime and Ariana.
29-Aug-2012 - The PRACS Institute has sold its Miami, US facility to a new early-phase focused CRO, CRI Phase I Corporation.
29-Aug-2012 - The lack of competing studies, proximity to the SFDA HQ and were the key drivers for the new Beijing, China office according to PRA International.
29-Aug-2012 - GlaxoSmithKline (GSK) and AstraZeneca have been attracted by NHS efforts to work with sponsors and CROs outside the UK according to Government investment group, UK Trade and Investment.
29-Aug-2012 - Charles River Laboratories has acquired Accugenix in a bid to expand its endotoxin and microbial detection portfolio.
28-Aug-2012 - United Drug (UD) has bought firms in the pharmacovigilance and market access sectors, following up on its acquisition in the contract packaging industry last week.
28-Aug-2012 - The UK’s National Health Service (NHS) has launched plans to provide services to the pharmaceutical industry internationally.
28-Aug-2012 - Health economics and outcomes research teams must have a greater influence over clinical trial design if pharma firms are to achieve reimbursement goals, according to Cutting Edge Information.
28-Aug-2012 - CROs conducting bioequivalence and bioavailability (BE/BA) studies for generics firms will have to log details of their sites with the US FDA under new ‘self-identification’ rules.
27-Aug-2012 - India’s IT sector must expand its knowledge base to fully meet the surge in demand for biostatistics says Alticure Research.
27-Aug-2012 - US Injectable drugmaker Hospira will invest $85m and create 200 new jobs at its plant in Rocky Mount, North Carolina according to the State Governor.
27-Aug-2012 - Precos will expand its portfolio of preclinical cancer models after being licensed to store and handle human tissue by the UK’s HTA.
24-Aug-2012 - Cobra Biologics claims a new micro bioreactor technology it has adopted can cut three months off cell line development timelines and facilitate faster production scale-up.
23-Aug-2012 - Comprehend Systems recently made its data analytics, visualisations and reports software available from the cloud. CEO Rick Morrison spoke with Outsourcing-Pharma.com about the firm’s reasoning, and why no rockets were...
23-Aug-2012 - Bend Research can now work with high-potency (HP) ingredients thanks to a new spray-drying facility.
23-Aug-2012 - United Drug wants the US courts to throw out accusations it disclosed confidential data about Catalent’s packaging business after secret acquisition talks collapsed last year.
22-Aug-2012 - West Pharmaceutical Services has started construction of a facility in Sri City, India, citing growing importance of the Asia-Pacific market.
22-Aug-2012 - ShangPharma saw a $10m lift in its Q2 revenues bolstered by increased business from its top ten clients.
22-Aug-2012 - Capsugel has launched a non-profit consortium in a bid to establish a lipid formulation classification system.
22-Aug-2012 - German CRO Verum.de wants to win business from US and North American sponsors keen to conduct trials in central and Eastern Europe (CEE).
21-Aug-2012 - United Drug will buy the UK and US trial supply businesses of Indian contractor Bilcare to further expand its packaging services division.
21-Aug-2012 - Genomic analysis seems to be an area of interest for the contract services sector at the moment with Northern Ireland-based Almac and US CRO Quintiles only the latest firms to...
21-Aug-2012 - MedPharm and Molecular Profiles have formed a dedicated topical medicine manufacturing service for clinical trials.
21-Aug-2012 - The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer....
21-Aug-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest movers and shakers in the world of pharmaceuticals, including news from INC Research, Elsevier and Invetech.
20-Aug-2012 - DaVita Clinical Research has opened a Phase I facility focussed on kidney research in a bid to meet a “growing demand” for renal trials.
20-Aug-2012 - The US FDA has revised its draft guidance on suicide risk in trials with updated terminology and expanded assessment criteria and has called for drug industry feedback.
20-Aug-2012 - Preclinical CRO Bioanalytical Systems (BASi) saw revenue, margins and gross profits fall during its fiscal third quarter but the firm is positive about the impact of recent restructuring efforts.
20-Aug-2012 - The EMA has issued new guidelines designed to help the pharmaceutical sector conduct trials of stroke prevention drugs in patients with atrial fibrillation (AF).
16-Aug-2012 - Pfizer wants the CROs, CMOs and other suppliers it works with to be green and says such firms have an advantage when it comes to winning contracts.
16-Aug-2012 - Theorem and Gallus say their new biologics manufacturing partnership is aimed at giving a “leg up” to drugsmakers in emerging markets looking to market products in the US.
16-Aug-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest new and changing faces in the pharmaceutical industry, including news from Parexel, Deloitte and Cerafor.
14-Aug-2012 - Chinese CRO Wuxi Pharmatech posted impressive revenue growth for Q2 driven by demand for lab services, but the firm still faced margin pressure due partly to rising labour costs.
14-Aug-2012 - Icon has boosted its Phase I translational medicine services in Manchester, UK, in preparation for what it believes will be a boom in the drug development area.
14-Aug-2012 - Longer-than-expected ramp up in new business gains for PDI has dragged on Q2 earnings results for the firm.
14-Aug-2012 - The US FDA wants CROs, sponsors and the wider industry to debate the pros and cons of current and evolving approaches to sharing study data.
13-Aug-2012 - The EMA wants CROs and sponsors to share their thoughts on plans to make data from clinical trials publicly available.
13-Aug-2012 - India’s biostatistics outsourcing market is set to grow 15 per cent in two years thanks to a 50 per cent cost saving compared with the West, according to a new survey.
13-Aug-2012 - BioClinica says the next eClinical revolution will be in programmes combining functionalities tailored to a client's specific needs.
09-Aug-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest pharma career changes, including news from Aesica, PharmaNet/i3 and Qforma.
09-Aug-2012 - ResearchNurses.co will conduct home visits in clinical trials for three Big Pharma firms after forging an agreement with Nottingham University Hospitals Research and Innovation Department.
09-Aug-2012 - US CRO Parexel saw revenue and income growth in fiscal Q4 but margins shrank in the firm’s clinical research and eClinical business.
09-Aug-2012 - Inspectors will be able to visit clinical trial sites unannounced and seize records under new draft guidelines issued by the Indian Central Drugs Standard Control Organisation (CDSCO).
08-Aug-2012 - Almac has doubled refrigerator capacity at its site in Craigavon, Northern Ireland citing demand from its roster of biologics producing clients.
08-Aug-2012 - Access to patient populations is a bigger deciding factor than low cost when selecting a Phase I service provider, according to ISR’s new quality benchmarking report.
08-Aug-2012 - Trends reversed at Charles River Laboratories in Q2 with preclinical services revenue (PCS) growing for the first time in 14 quarters while research models and services (RMS) sales fell for...
08-Aug-2012 - Aurobindo has announced long term plans to steer away from its generics making business in a bid to focus on long term API manufacturing partnerships.
08-Aug-2012 - US CMO Halo Pharma has asked the Drug Enforcement Administration (DEA) to renew its registration as a manufacturer of controlled substances.
07-Aug-2012 - DSM will conduct further cost cutting at its Pharma business as part of a wider ‘profit improvement initiative’ that will see it cut 1,000 jobs over the next 18 months.
07-Aug-2012 - Parexel may be willing to act as a matchmaker for the small and midsized developers that work with its new BioPharm unit according to COO Mark Goldberg.
07-Aug-2012 - The luggage Team USA took to the London 2012 Olympics was lighter than that carried to previous tournaments thanks to a technology provided by GE Healthcare.
07-Aug-2012 - Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and...
06-Aug-2012 - The CMO producing Natpara for NPS Pharmaceuticals has hit problems just as the company was preparing to submit its BLA.
06-Aug-2012 - Proposed law changes put before the US Senate and the House of Representatives last week seek to eliminate duplicate trials and force sponsors to display all results on Clinical trials.gov website....
06-Aug-2012 - West Pharmaceutical Services is sticking with plans to lessen CMO (contract manufacturing organisation) activities and boost proprietary products despite a hefty uptick in contract production in Q2.
06-Aug-2012 - Chinese contract research organisation (CRO) ShangPharma has called in JP Morgan to help independent board consider a takeover bid.
02-Aug-2012 - AmerisourceBergen has inked an $18.5bn deal to supply brand pharmaceuticals for Express Scripts' new mail order service.
02-Aug-2012 - AMRI’s once troubled Burlington facility has seen an uptick in new contracts and is showing strong potential for more, according to CEO Thomas D'Ambra.
02-Aug-2012 - Outsourcing-Pharma.com presents its latest round up of career moves in the pharmaceutical industry, including news from Theorem, FMC Technologies and EMD Serono.
02-Aug-2012 - Indian CROs continued to limit their spending in the second quarter as the weak rupee, fallout from Dateline and regulatory inertia hit business.
01-Aug-2012 - LabCorp says it is not in talks after rumours that it is a private-equity takeover target.
01-Aug-2012 - Medidata beat analyst expectations in this year’s Q2 results after inking a five-year $100m clinical cloud deal – the largest in the firm’s history.
01-Aug-2012 - AstraZeneca and Assay Depot have launched a new “virtual research lab” which they say will allow a small group of scientists to run full drug discovery from a laptop....
01-Aug-2012 - Lonza has brought in a new exec to oversee cost reduction and efficiency efforts at its largest custom API manufacturing plant in what CEO Richard Ridinger calls the Visp challenge. ...
|« Previous month||Next month »|